Bio-Techne Corp - Common Stock (NQ:TECH)

72.52 +0.06 (+0.08%)

Delayed Quote Updated: 2:51 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation ↗

June 20, 2023

RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22,

Via Benzinga

This Favorable Sign Appears On Bio-Techne's Chart ↗

May 31, 2023

Via Benzinga

This Analyst With 83% Accuracy Rate Sees Around 11% Upside In Texas Roadhouse - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

May 08, 2023

U.S stocks closed higher on Friday, with the Dow Jones jumping more than 500 points during the session.

Via Benzinga

What 4 Analyst Ratings Have To Say About Bio-Techne ↗

May 04, 2023

Via Benzinga

Bio-Techne: Q3 Earnings Insights ↗

May 03, 2023

Via Benzinga

7 Biotech Stocks That Could Cure Your Portfolio Woes ↗

April 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

Via InvestorPlace

Thursday Is Your Last Chance To Buy Bio-Techne Before The Dividend Payout ↗

February 07, 2023

Via Benzinga

Analyst Expectations for Bio-Techne's Future ↗

February 03, 2023

Via Benzinga

Earnings Outlook For Bio-Techne ↗

February 01, 2023

Via Benzinga

5 Cheapest Health Care Stocks You Should Think About ↗

January 27, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

5 Health Care Stocks That Are Diving - And May Rally ↗

January 19, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More ↗

December 15, 2022

The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Our 7 Top Biotech Stock Picks for 2023 ↗

December 09, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Via InvestorPlace

NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks ↗

August 16, 2022

Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.

Via Benzinga

Recap: Bio-Techne Q4 Earnings ↗

August 04, 2022

Bio-Techne (NASDAQ:TECH) reported its Q4 earnings results on Thursday, August 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Bio-Techne Q3 Earnings ↗

May 04, 2022

Bio-Techne (NASDAQ:TECH) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 ↗

January 10, 2023

Via Benzinga

Bio-Techne: Q1 Earnings Insights ↗

November 01, 2022

Bio-Techne (NASDAQ:TECH) reported its Q1 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022 ↗

December 14, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

Tackling Recurring Health Conditions Offers Hope to Patients

June 21, 2022

Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...

Via FinancialNewsMedia

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 19, 2022

On Monday, 429 stocks made new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 16, 2022

During Friday's session, 574 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

September 14, 2022

During Wednesday's session, 265 companies made new 52-week lows.

Via Benzinga

7 Defensive Growth Stocks to Buy for a Shaky Market ↗

May 21, 2022

These are the best defensive growth stocks to invest in now. Each of these can make great investments if/when the market sours.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

7 Superior Stocks That Smart Investors Will Buy on the Dip ↗

February 07, 2022

The recent sell-off presents long-term investors with many robust stocks to buy on the dip. These seven provide a start.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

June 14, 2022

On Tuesday, 951 companies hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗

April 25, 2022

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.